1. A Case of m0CRPC after Hormone Therapy for Pelvic Lymph Node Metastasis in which Salvage RARP was Effective
- Author
-
KOKUBUN, Hidetoshi, KUBOTA, Masashi, KAMBE, Takanari, MINE, Yuta, HAGIMOTO, Hiroki, YAMAGUCHI, Ritsuki, MURATA, Shiori, MAKITA, Noriyuki, HATTORI, Yuto, ABE, Yohei, TSUTSUMI, Naofumi, YAMASAKI, Toshinari, INOUE, Koji, and KAWAKITA, Mutsushi
- Subjects
Robot-assisted laparoscopic radical prostatectomy (RARP) ,494.9 ,Castration-resistant prostate cancer ,Salvage RARP - Abstract
The patient was a 63-year-old man with biopsy Gleason score of 4+5 prostate cancer with an initial prostate specific antigen level of (PSA) 51.2ng/ml. On imaging examination, extracapsular invasion, rectal invasion, and pararectal lymph node metastasis were found (cT4N1M0). After 4 years of androgen deprivation therapy, PSA decreased to 0.631ng/ml, and then increased gradually to1.2ng/ml. Computed tomographic scan showed that the primary tumor had shrunk and lymph node metastasis had disappeared; so salvage robot-assisted resection of the prostate (RARP) was performed for non-metastatic castration-resistant prostate cancer (m0CRPC). Since PSA decreased to an undetactable level, hormone therapy was terminated at 1 year. The patient remained recurrence-free for 3 years after surgery. RARP may be effective for m0CRPC, enabling discontinuation of androgen deprivation therapy.
- Published
- 2023